ICON3: A Phase 3 Study of Eltrombopag vs. Standard First-Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children

Project: Research project

Project Details

StatusActive
Effective start/end date3/31/208/31/50

Funding

  • Children's Hospital Boston
  • Novartis Pharmaceuticals Corporation